The chemical substance known as "3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-12,14,16-trihydroxycard-20(22)-enolide" is a type of cardenolide, which is a class of compounds characterized by their steroid structure and presence of a lactone ring. This particular compound features multiple hydroxyl groups, which contribute to its solubility and reactivity, and a glycosidic moiety that enhances its biological activity. The presence of the 6-deoxy-3-O-methylhexopyranosyl group suggests that it may exhibit specific interactions with biological targets, potentially influencing its pharmacological properties. Cardenolides are known for their effects on cardiac function, often used in medicinal applications for their ability to increase the force of heart contractions. The structural complexity, including the specific arrangement of hydroxyl groups and the glycoside, may also affect its stability, bioavailability, and overall efficacy. As with many natural products, the specific characteristics and activities of this compound can be influenced by its stereochemistry and the presence of substituents.

3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-12,14,16-trihydroxycard-20(22)-enolide

88660-21-3: The chemical substance known as "3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-12,14,16-trihydroxycard-20(22)-enolide" is a type of cardenolide, which is a class of compounds characterized by their steroid structure and presence of a lactone ring. This particular compound features multiple hydroxyl groups, which contribute to its solubility and reactivity, and a glycosidic moiety that enhances its biological activity. The presence of the 6-deoxy-3-O-methylhexopyranosyl group suggests that it may exhibit specific interactions with biological targets, potentially influencing its pharmacological properties. Cardenolides are known for their effects on cardiac function, often used in medicinal applications for their ability to increase the force of heart contractions. The structural complexity, including the specific arrangement of hydroxyl groups and the glycoside, may also affect its stability, bioavailability, and overall efficacy. As with many natural products, the specific characteristics and activities of this compound can be influenced by its stereochemistry and the presence of substituents.

4-[3-(3,5-dihydroxy-4-methoxy-6-methyl-oxan-2-yl)oxy-12,14,16-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one

CAS 88660-21-3

3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-12,14,16-trihydroxycard-20(22)-enolide

4-[3-(3,5-dihydroxy-4-methoxy-6-methyl-oxan-2-yl)oxy-12,14,16-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one

Ref: IN-DA0047VA